Evaluation of efficacy of topical nitric oxide in treatment of cutaneous leishmaniasis
Phase 2
- Conditions
- Cutaneous leishmaniasis.Cutaneous leishmaniasis
- Registration Number
- IRCT138710191535N1
- Lead Sponsor
- ?Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
age more than 12 years, less than 5 active lesion, no topical treatment from 2 weeks prior to study and no systemic treatment from 1 month prior to study,
Exclusion criteria: pregnancy and lactation, facial lesions, lesions with more than 4 months duration
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Complete improvement. Timepoint: Baseline, every other week. Method of measurement: measurment of erythema and induration diameter with a ruler.
- Secondary Outcome Measures
Name Time Method Side effects. Timepoint: every other week. Method of measurement: medical history taking and physical examination.